Diagnosis and treatment of new world hantavirus infections

Current Opinion in Infectious Diseases

Volumn 19, Issue 5, 2006, Pages 437-442

  Mertz, Gregory J ^a   Hjelle, Brian ^a   Crowley, Mark ^a   Iwamoto, Gary ^a   Tomicic, Vinko ^b   Vial, Pablo A ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

Extracorporeal membrane oxygenation; Hantavirus cardiopulmonary syndrome; New world hantavirus infections; Ribavirin

Indexed keywords

ANTIVIRUS AGENT; METHYLPREDNISOLONE; NEUTRALIZING ANTIBODY; RIBAVIRIN;

BLOOD SMEAR; CARDIOPULMONARY HEMODYNAMICS; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EXTRACORPOREAL OXYGENATION; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEART OUTPUT; HUMAN; INCUBATION TIME; INTENSIVE CARE; POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS; TREATMENT OUTCOME; VIRUS CULTURE; VIRUS TRANSMISSION;

HANTAVIRUS; HANTAVIRUS INFECTIONS; HEART DISEASES; HUMANS; PULMONARY EDEMA; SYNDROME;

EID: 33748368037     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qco.0000244048.38758.1f     Document Type: Review

References (38)

1. Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996; 24:252-258.
2. Nichol S, Spirpoulou C, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993; 262:914-917.
3. Chizhikov V, Spiropoulou C, Morzunov S, et al. Complete genetic characterization and analysis of isolation of sin nombre virus. J Virol 1995; 69:8132-8136.
4. Hjelle B, Jenison S, Mertz G, et al. Emergence of hantaviral disease in the southwestern United States. West J Med 1994; 161:467-473.
5. Hjelle B, Jenison S, Torrez-Martinez N, et al. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. J Virol 1994; 68:592-596.
6. Johnson AM, Bowen MD, Ksiazek TG, et al. Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 1997; 238:115-127.
7. Hjelle B, Krolikowski J, Torrez-Martinez N, et al. Phylogenetically distinct hantavirus implicated in a case of hantavirus pulmonary syndrome in the northeastern United States. J Med Virol 1995; 46:21-27.
8. Lopez N, Padula P, Rossi C, et al. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996; 220:223-226.
9. Morzunov SP, Feldmann H, Spiropoulou CF, et al. A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. J Virol 1995; 69:1980-1983.
10. Rollin PE, Ksiazek TG, Elliott LH, et al. Isolation of black creek canal virus, a new hantavirus from Sigmodon hispidus in Florida. J Med Virol 1995; 46:35-39.
11. Vincent MJ, Quiroz E, Gracia F, et al. Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology 2000; 277:14-19.
12. Mertz GJ. Bunyaviridae: bunyaviruses, phleboviruses, nairoviruses and hantaviruses. In: Richman DD, Whitley RJ, Hayden FG, editors. Clinical virology, 2nd ed. Washington, DC: ASM Press; 2002. pp. 921-948.
13. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis 1997; 3:95-104.
14. Smith JJ, Jeor S. Three-week incubation period for hantavirus infection. Pediatr Infect Dis J 2004; 23:974-975.
15. Merino C, Arias A, Castillo C. First case of hantavirus cardiopulmonary syndrome secondary to a rodent bite. Rev Chil Enf Respir 2002; 18:199-205.
16. Padula PJ, Edelstein A, Miguel SD, et al. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 1998; 241:323-330.
17. Wells RM, Sosa Estani S, Yadon ZE, et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis 1997; 3:171-174.
18. Martinez VP, Bellomo C, SanJuan J, et al. Person-to-person transmission of Andes virus. Emerg Infect Dis 2005; 11:1848-1853. The authors describe four clusters and suggest that person-to-person transmission probably occurred during the prodromal phase. The incubation period was estimated to be 15-24 days.
19. Torres-Pérez F, Navarrete-Droguett J, Aldunate R, et al. Peridomestic small mammals associated with confirmed cases of human hantavirus disease in southcentral Chile. Am J Trop Med Hyg 2004; 70:305-309.
20. Young J, Hansen GR, Graves TK, et al. The incubation period of hantavirus pulmonary syndrome. Am J Trop Med Hyg 2000; 62:714-717.
21. Vial PA, Valdivieso F, Mertz G, et al. Incubation period of hantavirus cardiopulmonary syndrome caused by Andes virus. Emerg Infect Dis 2006; 12 (In press).
22. Fritz CL, Young JC. Estimated incubation period for hantavirus pulmonary syndrome. Am J Trop Med Hyg 2001; 65:403.
23. Peters CJ, Khan AS. Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis 2002; 34:1224-1231.
24. Hjelle B, Glass GE. Outbreak of hantavirus infection in the Four Corners region of the United States in the wake of the 1997-1998 El Nino-southern oscillation. J Infect Dis 2000; 181:1569-1573.
25. Levy H, Simpson SQ. Hantavirus pulmonary syndrome. Am J Respir Crit Care Med 1994; 149:1710-1713.
26. Ketai LH, Williamson MR, Telepak RJ, et al. Hantavirus pulmonary syndrome: radiographic findings in 16 patients. Radiology 1994; 191:665-668.
27. Castillo C, Naranjo J, Sepulveda A, et al. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 2001; 120:548-554.
28. Koster FT, Foucar K, Hjelle B, et al. Presumptive diagnosis of hantavirus cardiopulmonary syndrome by routine complete blood count and blood smear review. Am J Clin Pathol 2001; 116:665-672.
29. Hjelle B, Jenison S, Torrez-Martinez N, et al. Rapid and specific detection of sin nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol 1997; 35:600-609.
30. Bharadwaj M, Nofchissey R, Goade D, et al. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 2000; 182:43-48.
31. Elgh F, Lundkvist A, Alexeyev OA, et al. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J Clin Microbiol 1997; 35:1122-1130.
32. Padula PJ, Rossi CM, Della Valle MO, et al. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol 2000; 49:149-155.
33. Galeno H, Mora J, Villagra E, et al. First human isolate of hantavirus (Andes virus) in the Americas. Emerg Infect Dis 2002; 8:657-661.
34. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995; 146:552-579.
35. Green W, Feddersen R, Yousef O, et al. Tissue distribution of hantavirus antigen in naturally infected humans and deer mice. J Infect Dis 1998; 177:1696-1700.
36. Tomicic V, Espinoza M, Torres J, et al. Addition of an arterio-venous shunt during veno-arterial extracorporeal life support in a patient with hantavirus pulmonary syndrome. Rev Med Chile 2005; 133:817-822. This is a case report on the use of ECMO.
37. Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991; 164:1119-1127.
38. Mertz GJ, Miedzinski L, Goade D, et al. Placebo-controlled, double-blind trial of intravenous ribavirin for hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004; 39:1307-1313.